Funding for this research was provided by:
National Heart, Lung, and Blood Institute (5KL2TR001419-02)
Cystic Fibrosis Foundation (Solomon18YO)
Received: 6 November 2018
Accepted: 2 April 2019
First Online: 25 April 2019
Ethics approval and consent to participate
: Ethics approval and informed consent was waived by the University of Alabama at Birmingham IRB committee due to the study being standard of care. The IRB protocol number is IRB-150922010.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.